1558O COVID-19 vaccine in participants (ptcpts) with cancer: Subgroup analysis of efficacy/safety from a global phase III randomized trial of the BNT162b2 (tozinameran) mRNA vaccine
暂无分享,去创建一个
N. Kitchin | S. Lockhart | R. Bailey | Ö. Türeci | W. Gruber | S. Dychter | Katherine F Liau | S. J. Thomas | U. Şahin | E. Lagkadinou | J. Pérez | S. Hariharan | X. Xu | C. Lu | T. Gentile